Mutations develop ovarian cancer. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy6

Cell Line, Tumor Tumor Cells, Cultured Cell Line Ovary Neoplastic Stem Cells Epithelial Cells

Organisms4

Mice, Nude Escherichia coli Mice, SCID Mice, Inbred BALB C

Diseases44

Ovarian Neoplasms Neoplasms, Glandular and Epithelial Cystadenocarcinoma, Serous Breast Neoplasms Genetic Predisposition to Disease Carcinoma Neoplasm Invasiveness Adenocarcinoma, Clear Cell Carcinoma, Endometrioid Lung Neoplasms Adenocarcinoma, Mucinous Peritoneal Neoplasms Prostatic Neoplasms Neoplasm Metastasis Neoplasms Ascites Colonic Neoplasms Disease Progression Stomach Neoplasms Endometrial Neoplasms Pancreatic Neoplasms Neoplasm Recurrence, Local Cystadenocarcinoma Neoplastic Syndromes, Hereditary Fallopian Tube Neoplasms Cell Transformation, Neoplastic Colorectal Neoplasms Adenocarcinoma Uterine Cervical Neoplasms Neoplasms, Cystic, Mucinous, and Serous Carcinoma, Non-Small-Cell Lung Carcinoma, Squamous Cell Genital Neoplasms, Female Hereditary Breast and Ovarian Cancer Syndrome Urinary Bladder Neoplasms Cystadenocarcinoma, Mucinous Neovascularization, Pathologic Disease Models, Animal Cystadenoma, Serous Breast Neoplasms, Male Syndrome Rectal Neoplasms Adenocarcinoma, Papillary Neoplasms, Multiple Primary

Chemicals and Drugs54

CA-125 Antigen BRCA2 Protein Antineoplastic Agents Tumor Markers, Biological Neoplasm Proteins BRCA1 Protein Cisplatin Paclitaxel RNA, Messenger DNA, Neoplasm Transcription Factors DNA-Binding Proteins Tumor Suppressor Protein p53 DNA Primers Carboplatin Antineoplastic Agents, Phytogenic Epididymal Secretory Proteins RNA, Small Interfering Nuclear Proteins Cancer Vaccines Codon, Nonsense Membrane Proteins Proto-Oncogene Proteins Receptor, erbB-2 Antigens, Neoplasm Tumor Suppressor Proteins Platinum Compounds Receptor, Epidermal Growth Factor Codon Platinum Carrier Proteins Receptors, Estrogen Antibodies, Monoclonal DNA Proto-Oncogene Proteins B-raf Recombinant Proteins Protein-Serine-Threonine Kinases RNA, Neoplasm Topotecan ras Proteins Genetic Markers Proteins MicroRNAs Antigens, Tumor-Associated, Carbohydrate Taxoids Mutant Proteins Proto-Oncogene Proteins c-akt Receptors, Progesterone Repressor Proteins Protein Kinase Inhibitors Organoplatinum Compounds Adaptor Proteins, Signal Transducing Tamoxifen Recombinant Fusion Proteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment66

Early Detection of Cancer Pedigree Polymerase Chain Reaction DNA Mutational Analysis Genetic Testing Prognosis Neoplasm Staging Reverse Transcriptase Polymerase Chain Reaction Survival Analysis Antineoplastic Combined Chemotherapy Protocols Xenograft Model Antitumor Assays Amino Acid Substitution Gene Expression Profiling Blotting, Western Survival Rate Transfection Immunohistochemistry Risk Factors Disease-Free Survival Sequence Analysis, DNA Risk Mutagenesis, Site-Directed Retrospective Studies Prospective Studies Neoplasm Transplantation Follow-Up Studies Oligonucleotide Array Sequence Analysis Sensitivity and Specificity Case-Control Studies Chromosome Mapping Risk Assessment Odds Ratio Kaplan-Meier Estimate Transplantation, Heterologous Registries Combined Modality Therapy Treatment Outcome Drug Screening Assays, Antitumor Models, Biological Tissue Array Analysis Cohort Studies Models, Molecular Multivariate Analysis Models, Genetic Neoplasm Grading Tumor Burden Disease Models, Animal Gene Knockdown Techniques Reproducibility of Results Cloning, Molecular Predictive Value of Tests Incidence Heterozygote Detection Chemotherapy, Adjuvant Molecular Targeted Therapy Drug Administration Schedule Immunoenzyme Techniques Questionnaires Logistic Models Sequence Alignment Clinical Trials as Topic Confidence Intervals Genetic Complementation Test SEER Program Flow Cytometry Salpingectomy

Psychiatry and Psychology1

Phenomena and Processes74

Point Mutation Mutation, Missense Mutation Germ-Line Mutation Frameshift Mutation Genes, BRCA1 Gene Expression Regulation, Neoplastic Genes, BRCA2 Drug Resistance, Neoplasm Genetic Predisposition to Disease Heterozygote Base Sequence Exons Genotype Alleles Mutation Rate Polymorphism, Single-Stranded Conformational Amino Acid Substitution Amino Acid Sequence Cell Proliferation Phenotype Transfection Genes, p53 Apoptosis Polymorphism, Genetic Signal Transduction Promoter Regions, Genetic Homozygote Risk DNA Methylation Cell Survival Founder Effect Codon, Nonsense Mutagenesis Sensitivity and Specificity Sequence Deletion Genes, Tumor Suppressor Cell Division Gene Expression Protein Structure, Tertiary Odds Ratio Protein Binding Gene Deletion Cell Movement Genes, Dominant Down-Regulation Cell Cycle Dose-Response Relationship, Drug Genes, Recessive Transcription, Genetic Loss of Heterozygosity Codon Binding Sites Gene Silencing Up-Regulation Phosphorylation RNA Interference Cell Growth Processes Gene Frequency Time Factors DNA Repair Microsatellite Repeats Genetic Variation Sequence Homology, Amino Acid Suppression, Genetic Genetic Linkage Genetic Markers Genes, Neoplasm Gene Amplification Plasmids Penetrance Polymorphism, Single Nucleotide Drug Synergism Gene Dosage

Disciplines and Occupations3

Immunohistochemistry Genetic Counseling Medical Oncology

Anthropology, Education, Sociology and Social Phenomena1

National Cancer Institute (U.S.)

Information Science8

Base Sequence Molecular Sequence Data Survival Rate Amino Acid Sequence Registries Incidence Questionnaires SEER Program

Named Groups3

Jews Survivors Asian Continental Ancestry Group

Health Care31

Genetic Testing Survival Analysis Survival Rate Risk Factors Disease-Free Survival Risk Retrospective Studies Prospective Studies Follow-Up Studies Family Health Sensitivity and Specificity Case-Control Studies Risk Assessment Odds Ratio Kaplan-Meier Estimate Age Factors Registries Treatment Outcome Age of Onset Cohort Studies Multivariate Analysis Genetic Counseling Reproducibility of Results Predictive Value of Tests Incidence National Cancer Institute (U.S.)Questionnaires Logistic Models Clinical Trials as Topic Confidence Intervals SEER Program

Geographicals2

United States China

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Information Science Named Groups Health Care Geographicals

Ovarian Neoplasms Point Mutation Mutation, Missense Neoplasms, Glandular and Epithelial Mutation Germ-Line Mutation CA-125 Antigen Frameshift Mutation Cystadenocarcinoma, Serous Genes, BRCA1 Cell Line, Tumor Early Detection of Cancer Pedigree Breast Neoplasms Gene Expression Regulation, Neoplastic Genes, BRCA2 Drug Resistance, Neoplasm Genetic Predisposition to Disease Carcinoma Heterozygote BRCA2 Protein Base Sequence Antineoplastic Agents Polymerase Chain Reaction Tumor Markers, Biological DNA Mutational Analysis Mice, Nude Exons Genotype Neoplasm Proteins BRCA1 Protein Neoplasm Invasiveness Adenocarcinoma, Clear Cell Genetic Testing Prognosis Molecular Sequence Data Alleles Cisplatin Neoplasm Staging Paclitaxel Reverse Transcriptase Polymerase Chain Reaction Carcinoma, Endometrioid Mutation Rate Lung Neoplasms RNA, Messenger Polymorphism, Single-Stranded Conformational Survival Analysis DNA, Neoplasm Adenocarcinoma, Mucinous Peritoneal Neoplasms Prostatic Neoplasms Neoplasm Metastasis Neoplasms Antineoplastic Combined Chemotherapy Protocols Xenograft Model Antitumor Assays Ascites Tumor Cells, Cultured Amino Acid Substitution Gene Expression Profiling Colonic Neoplasms Blotting, Western Survival Rate Amino Acid Sequence Cell Proliferation Transcription Factors Disease Progression DNA-Binding Proteins Stomach Neoplasms Phenotype Transfection Tumor Suppressor Protein p53 DNA Primers Immunohistochemistry Genes, p53 Apoptosis Polymorphism, Genetic Risk Factors Signal Transduction Carboplatin Disease-Free Survival Promoter Regions, Genetic Sequence Analysis, DNA Endometrial Neoplasms Antineoplastic Agents, Phytogenic Homozygote Risk Pancreatic Neoplasms Neoplasm Recurrence, Local Cystadenocarcinoma Epididymal Secretory Proteins RNA, Small Interfering DNA Methylation Mutagenesis, Site-Directed Neoplastic Syndromes, Hereditary Cell Line Nuclear Proteins Fallopian Tube Neoplasms Ovary Jews Retrospective Studies

No FAQ available that match "mutations develop ovarian cancer"